Francis P. Worden, MD, discusses how the effectiveness of lenvatinib in this real-world setting compares with results from ...

An expert from the CURE® advisory board explains the likely treatability of Dave Coulier’s non-Hodgkin lymphoma.

Insurance hurdles worsen delays, force abandoned treatments, and result in hospitalizations and deaths, radiation oncologists ...

When Julie Durbin was undergoing cancer treatment, she was always cold. She would bring a cardigan, a sweater that opens in ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Bladder Cancer Course and the session Metastatic ...

BeiGene’s Test Before Treat campaign and partnership with the CLL Society aims to educate cancer patients about the ...

Sonodynamic therapy doubled the median overall survival to 15.7 months and tripled progression-free survival to 5.5 months in ...

The physician and surgeon was diagnosed with glioblastoma in 2020 while she was pregnant with her son. Although the cancer ...

Joe Faratzis, a 34-year-old who was diagnosed with stage 4 colorectal cancer in 2019, has undergone multiple treatments, ...

Rapper and social media personality Bhad Bhabie disclosed last month that she was undergoing treatment for cancer. And now, ...

The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...

Radiation oncologists report that prior authorization requirements can lead to treatment delays that cause patients to abandon treatment, be hospitalized, become disabled, and even die.